enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. DexCom Is Great. Here's Why You Shouldn't Buy It. - AOL

   www.aol.com/dexcom-great-heres-why-shouldnt...

   As a result, DexCom's trailing 12-month (TTM) revenue and net income have grown steadily over the past five years, reaching sales of $3.9 billion and net income of $666.9 million. Take a look at ...

3. Dexcom - Wikipedia

   en.wikipedia.org/wiki/Dexcom

   Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. [3] [4] In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours ...

4. Continuous glucose monitor - Wikipedia

   en.wikipedia.org/wiki/Continuous_glucose_monitor

   In June 2024, Senseonics announced intent to launch sales of the 365-day sensor in 2025. [35] A solution built by U.S. firm GlySens, aimed to remove the need for an external reader by creating a sensor that could be implanted under the skin, that directly transmitted glucose values to an external app. As of August 2023, this undertaking has ...

5. Automated insulin delivery system - Wikipedia

   en.wikipedia.org/wiki/Automated_insulin_delivery...

   ACE insulin pumps allow users to integrate continuous glucose monitors, automated insulin dosing (AID) systems, and other diabetes management devices with the pump to create a personalized diabetes therapy system. Many users of the t:slim X2 integrate the pump with the Dexcom G6, a continuous glucose monitor approved by the FDA in 2018.

6. 1 Reason to Sell DexCom Stock, and 1 Reason to Buy - AOL

   www.aol.com/1-reason-sell-dexcom-stock-114500360...

   Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a ...

7. Where Will DexCom Be in 5 Years? - AOL

   www.aol.com/where-dexcom-5-years-120000658.html

   More recently, DexCom launched Stelo, an over-the-counter CGM option for type 2 diabetes patients not using insulin, and for people with pre-diabetes. We can expect much more progress of this sort ...